ClinicalTrials.gg
Sign In

DrugBiological

MT027 clinical trials

studies test it
5
open now
5
in phase 3
0
first study started
2024

Keep track of what changes. Save the MT027 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

MT027 cells suspension
3

Development codes

MT027
1

Studies by the year they started

5 studies that test it; most in 2025 (3)

Studies that test MT027, by start year
YearStudies
20241
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
1

What it is tested for

Each study’s main condition, where its own words name it.

Neoplasms
2
Central Nervous System Neoplasms
1
Glioma
1

Who runs them

Industry 3 · Other 2

Suzhou Maximum Bio-tech Co., Ltd. (3) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Zhejiang University (1)

Often tested with

Tested in the same studies.

Izalontamab brengitecan (1) · CVL006 (1) · KXV01 (1) · QH101 (1) · META10 (1) · TAEST1901 (1) · TCN 201 (1) · Base Edited Natural Killer Cells NK510 (1)

Studies

Open first, then newest update. How each study uses MT027 is read from its arms, and is right about nine times in ten.

Testing it · 5